Eyris Pte Ltd

EyRIS aims to transfigure the delivery of healthcare through AI-powered solutions, with the ultimate goal of being the game changer in the future of first-stage medical diagnostics. Its foray into the healthcare industry focuses on the development and commercialisation of innovative products to revolutionise the detection of retinal and chronic diseases.

Our flagship product, SELENA+, is an AI with Deep Learning System that can detect three retinal diseases: diabetic retinopathy, glaucoma suspect, and age-related macular degeneration. SELENA+ has transcended significant geographical barriers by establishing its presence in 26 countries today, a feat that required careful navigation around various regulatory approvals.